0000899243-22-010796.txt : 20220311 0000899243-22-010796.hdr.sgml : 20220311 20220311210023 ACCESSION NUMBER: 0000899243-22-010796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Astle Christopher CENTRAL INDEX KEY: 0001915257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 22734889 MAIL ADDRESS: STREET 1: 114 EAST 4TH AVENUE, SUITE 800 CITY: VANCOUVER STATE: A1 ZIP: V5T 1G4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 800 - 114 EAST 4TH AVENUE CITY: Vancouver STATE: A1 ZIP: V5T 1G4 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: SUITE 800 - 114 EAST 4TH AVENUE CITY: Vancouver STATE: A1 ZIP: V5T 1G4 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-10 0 0001403752 Zymeworks Inc. ZYME 0001915257 Astle Christopher C/O ZYMEWORKS INC. 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4 BRITISH COLUMBIA, CANADA 0 1 0 0 SVP & Chief Financial Officer Stock Option (Right to Buy) 7.00 2022-03-10 4 A 0 125000 0.00 A 2032-03-09 Common Shares 125000 125000 D Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date. /s/ Daniel Dex, Attorney-in-Fact 2022-03-11